Director · PUMA BIOTECHNOLOGY, INC. · Common Stock
Side
SELL
Value
$121K
Shares
15.0K
Price
$8.1
Executed
Nov 11, 2026
Disclosed
Nov 13, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Nov 11 executedNov 13, 2026 disclosed
PBYI · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Other disclosed activity · PBYI
No records
No other disclosures for this security in the dataset.
Evidence
Verified data
Read directly from the primary public document; every field below is as reported by the filer.
MILLER MICHAEL PATRICK filed this Form 4 reporting a open-market sale of PBYI on Nov 11, 2026. It became public on Nov 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
MILLER MICHAEL PATRICKcik:0001236514
Issuer
PUMA BIOTECHNOLOGY, INC.cik:0001401667
Revision history · 0
No field has changed since this record was first ingested.
